Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Long-Term Investments (2018)

Akebia Therapeutics (AKBA) has disclosed Long-Term Investments for 1 consecutive years, with $245000.0 as the latest value for Q4 2018.

  • Quarterly Long-Term Investments changed N/A to $245000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $245000.0 through Dec 2018, changed N/A year-over-year, with the annual reading at $245000.0 for FY2018, N/A changed from the prior year.
  • Long-Term Investments for Q4 2018 was $245000.0 at Akebia Therapeutics.
  • The five-year high for Long-Term Investments was $245000.0 in Q4 2018, with the low at $245000.0 in Q4 2018.